You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
Brief News on Innovation
Company News Brief News on Innovation
PEIJIA MEDICAL RECEIVES THE NMPA APPROVAL FOR THE REGISTRATION APPLICATION OF TaurusMax™ TAVR SYSTEM
2024-08-15 14:43:28

Peijia Medical received the NMPA approval for the registration application of TaurusMax™ in August 15, 2024. TaurusMaxTM is an iteration of TaurusElite®, with the following advantages: 

1) Commissural Alignment: ensuring proper alignment of the commissures to protect the coronary artery pathways, safeguarding the patients’ entire life cycle; 

2) Vision+ Marker: a clear visualization ring at the base for accurate judgment of implantation depth; 3) A2 FlexTM Dual-Axis Bending: optimizing coaxiality for precise implantation.

企业微信截图_20240826111330.png


Top